Deal Announcements

Vaccinogen Brings In New Venture Capital Financing

Tuesday, March 16, 2010 5:57:00 AM PDT | VentureDeal Staff

Frederick, Maryland  --  Biotechnology research company Vaccinogen has secured $2.5 million in new round of venture capital investment.

Vaccinogen is producing what it calls its "the only immunotherapy for stage II colon cancer."

Investors in the round were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1